# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049811
Filing Date
2024-04-29
Accepted
2024-04-29 16:00:07
Documents
5
Period of Report
2024-06-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | glto-2024-def_14a_v2.htm | DEF 14A | 909874
2 | GRAPHIC | img137670263_0.jpg | GRAPHIC | 10035
3 | GRAPHIC | img137670263_1.jpg | GRAPHIC | 3329
4 | GRAPHIC | img137670263_2.jpg | GRAPHIC | 456016
5 | GRAPHIC | img137670263_3.jpg | GRAPHIC | 203154
| Complete submission text file | 0000950170-24-049811.txt |  | 1837129

Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39655 | Film No.: 24890418
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)